Unlimited Use of Infant Dyspnea Medications

Published: 2004-12-03 06:59:00

Updated: 2004-12-03 06:59:00

The Ministry of Health and Welfare (MOHW) announced it would allow for an unlimited use of infant dyspnea (respiratory distress syndrome) medications, given the medical judgment by healthcare professionals.

The existing measure on the limited use of infant dyspnea medications seriously affe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK